BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15454249)

  • 1. French version of FACT-G: validation and comparison with other cancer-specific instruments.
    Conroy T; Mercier M; Bonneterre J; Luporsi E; Lefebvre JL; Lapeyre M; Puyraveau M; Schraub S
    Eur J Cancer; 2004 Oct; 40(15):2243-52. PubMed ID: 15454249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires.
    Cheung YB; Goh C; Thumboo J; Khoo KS; Wee J
    J Clin Oncol; 2005 Aug; 23(22):4936-44. PubMed ID: 16051946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
    Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research.
    Holzner B; Bode RK; Hahn EA; Cella D; Kopp M; Sperner-Unterweger B; Kemmler G
    Eur J Cancer; 2006 Dec; 42(18):3169-77. PubMed ID: 17045472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC).
    Mercier M; Bonneterre J; Schraub S; Lecomte S; el Hasnaoui A
    Bull Cancer; 1998 Feb; 85(2):180-6. PubMed ID: 9752337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison.
    Brédart A; Mignot V; Rousseau A; Dolbeault S; Beauloye N; Adam V; Elie C; Léonard I; Asselain B; Conroy T
    Patient Educ Couns; 2004 Aug; 54(2):207-12. PubMed ID: 15288916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP).
    Rodary C; Pezet-Langevin V; Garcia-Acosta S; Lesimple T; Lortholary A; Kaminsky MC; Bennouna J; Culine S; Bourgeois H; Fizazi K
    Eur J Cancer; 2004 Mar; 40(4):521-8. PubMed ID: 14962718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of instruments for measuring quality of life in patients with lung cancer.
    Hollen PJ; Gralla RJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):31-40. PubMed ID: 8610235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
    Jensen K; Bonde Jensen A; Grau C
    Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA; Denic S; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():146-54. PubMed ID: 18837895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
    Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
    Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.